Neurovascular Product Surveillance Registry

Recruiting now

Conditions studied: Intracranial Aneurysm, Stroke, Ischemic

In brief

Post market surveillance registry

Key facts

Study ID: NCT02988128
Run by: Medtronic Neurovascular Clinical Affairs
People needed: 4000
Starts: 2016-12-01
Expected to finish: 2032-08-01
Last updated by the study team: 2026-06-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements
Patient has, or is intended to receive or be treated with, an eligible Medtronic product
Patient is consented within the enrollment window of the therapy received, as applicable
Patient is at least 18 years of age at time of enrollment.

You may not qualify if…

Patient who is, or is expected to be inaccessible for follow-up
Patient with exclusion criteria required by local law
Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
For MDT24028 and MDT22032:
General Inclusion Criteria:
Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements.
Patient is treated or intended to be treated with an eligible Medtronic Neurovascular product.
Patient is an adult per local law at time of consent. Medtronic Business Restricted This document is electronically controlled CONFIDENTIAL 056-F275 Rev F Clinical Investigation Plan Template
General Exclusion Criteria:
Patient who may be unable to complete the study follow-up
Patient with any contraindications per the applicable Instructions for Use document
Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study
Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results.
Additional criteria may be required, refer to cohort-specific Addendum, as applicable, for further guidance.

Where it is running

LMU Klinikum der Universität München — Munich, Germany (enrolling)
CINRE s.r.o. — Bratislava, Slovakia (enrolling)
CHU de Montpellier - Hôpital Gui de Chauliac — Montpellier, France (enrolling)
Universitätsklinikum Heidelberg — Heidelberg, Germany (enrolling)
Hellenic Airforce 251 General Hospital — Athens, Greece (enrolling)
Azienda Ospedaliera Ospedale Niguarda Cà Granda — Milan, Italy (enrolling)
Hôpital Pierre Wertheimer — Bron, France (enrolling)
Hôpital de la Timone-CHU de Marseille — Marseille, France (enrolling)
CHU Hôpitaux de Rouen - Hôpital Charles Nicolle — Rouen, France (enrolling)
Universitätsklinikum Freiburg — Freiburg im Breisgau, Germany (enrolling)
Universitätsklinikum Christian Doppler Klinik Salzburg — Salzburg, Austria (enrolling)
Klinikum Nürnberg - Klinikum Nürnberg Süd — Nuremberg, Germany (enrolling)
Országos Klinikai Idegtudományi Intézet — Budapest, Hungary (enrolling)
Sheba Medical Center — Ramat Gan, Israel (enrolling)
ENERI — Buenos Aires, Argentina (enrolling)
CHU Brest, Hôpital de la Cavale Blanche — Brest, France (enrolling)
AP-HP Hôpital Bicêtre — Le Kremlin-Bicêtre, France (enrolling)
CHU Limoges - Hôpital Dupuytren — Limoges, France (enrolling)
Fondation Ophtalmologique Adolphe de Rothschild — Paris, France (enrolling)
Hôpital de la Pitié Salpétrière — Paris, France (enrolling)
CHU Toulouse - Hôpital Pierre-Paul Riquet — Toulouse, France (enrolling)
CHRU de Tours - Hôpital Brettoneau — Tours, France (enrolling)
Rigshospitalet — Copenhagen, Denmark (enrolling)
Turun Yliopistollinen keskussairaala — Turku, Finland (enrolling)
Hospital Vall D'Hebron — Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.